
Shukun Technology
Founded Year
2017Stage
Series D | AliveTotal Raised
$250.65MValuation
$0000Last Raised
$108.09M | 4 yrs agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
-17 points in the past 30 days
About Shukun Technology
Shukun Technology provides smart medical and health technology platform services. The company offers a suite of artificial intelligence-powered diagnostic assistance products that cover common and significant diseases across various human body parts. Shukun Technology also provides comprehensive solutions for medical imaging, surgical planning, and health management, leveraging multimodality technology and original research to serve the healthcare industry. It was founded in 2017 and is based in Beijing, China.
Loading...
Shukun Technology's Products & Differentiators
digital body
digital body
Loading...
Research containing Shukun Technology
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Shukun Technology in 1 CB Insights research brief, most recently on Dec 7, 2022.
Expert Collections containing Shukun Technology
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Shukun Technology is included in 4 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,309 items
Digital Health
12,122 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Digital Health 50
150 items
The winners of the third annual CB Insights Digital Health 150.
Artificial Intelligence (AI)
9,236 items
Latest Shukun Technology News
Oct 13, 2025
13 October 2025 Disclaimer - this article is provided by Excellence First Enterprise Consultancy (EFEC) , reflecting our role as a trusted bridge between the UK and China in talent, innovation, and life sciences - connecting people and ideas to advance collaboration across borders. At the recent Medical Artificial Intelligence Conference (MAIC) in Beijing, a milestone was announced that deserves global attention: the launch of the world’s first AI doctor dedicated to geriatrics. Developed by Beijing Geriatric Hospital in partnership with Shukun Technology, this system — nicknamed AI Dr. Xiaoxiang — achieved a striking 95% diagnostic concordance with senior clinical teams in complex multi-disciplinary cases. This achievement is not only a step forward for China’s healthcare system, but also a sign of what is possible when technology is embedded into healthcare at a systems level. For the UK, where ageing populations and medical workforce pressures are among the most urgent challenges, the development opens space for reflection, collaboration, and exchange. The Challenge of Ageing Populations Geriatrics is widely recognised as one of the most complex areas of medicine. Elderly patients often present with multiple conditions, atypical symptoms, rapid disease progression, and the risks of polypharmacy. Managing this complexity has traditionally required resource-intensive multi-disciplinary collaboration, at a time when both the UK and China face shortages of specialist doctors. By embedding expert clinical reasoning into AI models, the Beijing project has shown how digital systems can help extend scarce expertise without diluting quality. For societies everywhere navigating demographic change, this represents a powerful proof of concept. The AI-Enabled Hospital: A Systems-Level Advance What makes the Chinese breakthrough particularly notable is not only the creation of an AI geriatric doctor, but its integration into a broader AI-enabled hospital system. Beijing Geriatric Hospital is deploying AI across the full patient journey: Pre-admission: AI triage and consultation tools help patients prepare before hospital visits. In-hospital: AI-driven imaging analysis and automated medical records improve accuracy and reduce administrative burdens. Post-discharge: Remote monitoring and coordination platforms link hospitals with community care and home-based services across multiple districts. This approach moves AI beyond isolated pilots (such as single-department radiology projects) into a coordinating infrastructure across an entire hospital ecosystem. It demonstrates how AI can become a connective layer supporting continuity of care. For the UK, this offers valuable insight. The NHS has world-class expertise in medical research and governance, yet integration across regions and services remains a challenge. The Chinese experience shows how a hospital can serve as a testbed for whole-system AI deployment, raising the possibility of similar pilots in UK integrated care systems. Relevance Across the UK This systems approach has echoes of challenges faced across the UK — from Cambridge and London, to the Midlands, the North East, and rural Wales. Everywhere, healthcare providers are seeking to bridge hospital, primary care, and community services more effectively. The Beijing project demonstrates how AI, applied holistically, can support not just individual tasks but continuity of care across the system. Opportunities for UK–China Collaboration This development is best viewed as a shared opportunity for innovation and exchange. For the UK, three themes stand out: Specialisation – China’s geriatric AI initiative shows the value of focusing AI on areas of system-level pressure, complementing UK work in oncology, imaging, and workflow automation. Integration – Both countries share concerns about fragmented pathways; AI can help connect services across hospital and community settings. Partnership – The UK’s strengths in ethics, governance, and translational research align well with China’s strengths in large-scale deployment. Together, these form complementary ground for international collaboration. A Shared Horizon The launch of AI Dr. Xiaoxiang is not the end of a journey but the beginning of a new phase in healthcare innovation. Shukun Technology has set its ambition clearly: to provide a digital doctor for every patient, and a digital assistant for every clinician. For the UK, the question is not whether AI will transform geriatric medicine, but how to ensure this transformation benefits patients, supports clinicians, and reflects societal and cultural values. As ageing reshapes healthcare globally, there is a need — and an opportunity — for the UK and China to work together. The conversation is not about who leads and who follows, but about how shared innovation can improve lives across both societies. Image: The world’s first AI doctor for geriatrics highlights how AI-enabled hospital systems could shape the future of healthcare 13 October 2025
Shukun Technology Frequently Asked Questions (FAQ)
When was Shukun Technology founded?
Shukun Technology was founded in 2017.
Where is Shukun Technology's headquarters?
Shukun Technology's headquarters is located at Qiyang Road, Beijing.
What is Shukun Technology's latest funding round?
Shukun Technology's latest funding round is Series D.
How much did Shukun Technology raise?
Shukun Technology raised a total of $250.65M.
Who are the investors of Shukun Technology?
Investors of Shukun Technology include Marathon Venture Partners, HongShan, Goldman Sachs Asset Management, Jane Street Group, WT Focus on China Fund and 16 more.
Who are Shukun Technology's competitors?
Competitors of Shukun Technology include Thorough Future and 4 more.
What products does Shukun Technology offer?
Shukun Technology's products include digital body.
Loading...
Compare Shukun Technology to Competitors

Yizhun Intelligence focuses on the development of artificial intelligence that assists medical imaging diagnosis. The company was founded in 2017 and is based in Beijing, China.
Shenzhi Technology focuses on ultrasound diagnostic intelligence and ultrasound AI applications for thyroid, breast, liver, carotid plaque, pelvic floor, orthopedics, neurology, and other diseases.
Provider of medical image analytics solutions. The company specializes in the development of artificial intelligence (AI) powered medial image analytics solutions. The products are applied in medical image automatic detection and diagnosis, surgery planning, navigation and evaluation.
RAMZED operates in digital medical imaging technology within the healthcare sector. The company provides ultrasonic color Doppler diagnostic systems, non-invasive color Doppler ultrasound systems, and digital X-ray imaging systems that assist in medical diagnostics. RAMZED serves the medical equipment industry, with a focus on solutions for healthcare providers. It is based in Yueyang, Hunan.

Ultromics operates within the medical technology industry and focuses on heart failure detection. The company offers diagnostic tools that analyze echocardiograms to identify conditions such as heart failure with preserved ejection fraction (HFpEF) and cardiac amyloidosis, providing clinicians with reports to assist in clinical decisions. Ultromics serves healthcare providers, including hospitals and clinics, by integrating its technology into existing medical imaging workflows. It was founded in 2017 and is based in Oxford, England.

Knowledge Vision aims to use artificial intelligence to help doctors in making accurate diagnosis through medical artificial intelligence and medical image processing technologies.
Loading...
